XML 13 R6.htm IDEA: XBRL DOCUMENT v3.21.2
UNAUDITED CONSOLIDATED STATEMENTS OF CASHFLOWS
$ in Thousands
9 Months Ended
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
OPERATING ACTIVITIES    
Net income/(loss) $ 514,804 $ (206,572)
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:    
Depreciation and amortization 79,488 81,097
Amortization of deferred charges and guarantees, net 2,003 3,037
Equity in net losses of affiliates 561 391
Net (income)/loss from discontinued operations (568,047) 180,469
Dry-docking expenditure (1,591) (8,400)
Compensation cost related to employee stock awards 3,022 4,251
Net foreign exchange losses 814 613
Change in fair value of investment in listed equity securities 244,210 0
Changes in assets and liabilities:    
Trade accounts receivable (96) 7,017
Inventories 456 (3,195)
Other current and non-current assets 4,457 (16,713)
Amounts due to/from related companies (9,269) (1,303)
Trade accounts payable (288) 2,542
Accrued expenses 77 6,013
Other current and non-current liabilities 62,324 (53,151)
Net cash provided by operating activities 169,086 86,399
Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]    
Additions to investments in affiliates   (8,316)
Dividends received from listed equity securities   0
Net Cash Provided by (Used in) Investing Activities, Discontinued Operations [Abstract]    
Additions to investments in affiliates   (8,316)
Dividends received   0
Short-term loan advanced to related parties   0
Proceeds from repayment of short-term loan advanced to related parties   0
FINANCING ACTIVITIES    
Proceeds from short-term and long-term debt 122,920 539,307
Repayments of short-term and long-term debt (208,250) (548,623)
Cash dividends paid (24,437) (16,020)
Financing costs paid (5,299) (7,563)
Purchase of treasury shares (24,484) (16,650)
Net cash used in financing activities (139,550) (49,549)
Net decrease in cash, cash equivalents and restricted cash (22,702) (171,517)
Cash, cash equivalents and restricted cash at beginning of period 290,872 410,412
Cash, cash equivalents and restricted cash at end of period 268,170 238,895
Supplemental Cash Flow Information [Abstract]    
Cash and cash equivalents 123,690 76,696
Restricted cash and short-term deposits 71,647 100,748
Restricted cash (non-current portion) 72,833 61,451
Cash, cash equivalents, restricted cash and restricted cash equivalents 268,170 238,895
Results from discontinued operations    
Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]    
Additions to investments in affiliates 0 (2,410)
Dividends received from listed equity securities 460 10,124
Net Cash Provided by (Used in) Investing Activities, Discontinued Operations [Abstract]    
Additions to investments in affiliates 0 (2,410)
Dividends received 460 10,124
Net proceeds from disposals of investments in affiliates 119,560 0
Short-term loan advanced to related parties 0 (40,000)
Proceeds from repayment of short-term loan advanced to related parties 0 40,000
Net cash provided by discontinued investing activities 120,020 7,714
Total results from continuing operations    
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:    
Depreciation and amortization 79,488 81,097
Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]    
Additions to vessels and equipment (925) (3,696)
Additions to assets under development (183,305) (211,167)
Additions to investments in affiliates (8,625) (8,316)
Dividends received from listed equity securities 3,725 0
Proceeds from subscription of equity interest in Gimi MS Corporation 16,872 7,098
Net cash used in continuing investing activities (172,258) (216,081)
Net Cash Provided by (Used in) Investing Activities, Discontinued Operations [Abstract]    
Additions to investments in affiliates (8,625) (8,316)
Dividends received 3,725 0
Oil and gas derivative    
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:    
Change in fair value of other derivative instruments (145,282) 39,400
Other Contract    
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:    
Change in fair value of other derivative instruments $ (18,557) $ 50,903